Mundorf A, Semmler A, Heidecke H, Schott M, Steffen F, Bittner S
Vaccines (Basel). 2024; 12(7).
PMID: 39066428
PMC: 11281408.
DOI: 10.3390/vaccines12070790.
Nunes M, Vlok M, Proal A, Kell D, Pretorius E
Cardiovasc Diabetol. 2024; 23(1):254.
PMID: 39014464
PMC: 11253362.
DOI: 10.1186/s12933-024-02315-x.
Hoffmann K, Hainzl A, Stingl M, Kurz K, Biesenbach B, Bammer C
Wien Klin Wochenschr. 2024; 136(Suppl 5):103-123.
PMID: 38743348
PMC: 11093804.
DOI: 10.1007/s00508-024-02372-y.
Seton K, Espejo-Oltra J, Gimenez-Orenga K, Haagmans R, Ramadan D, Mehlsen J
J Clin Med. 2024; 13(2).
PMID: 38256459
PMC: 10816159.
DOI: 10.3390/jcm13020325.
Rohrhofer J, Hauser L, Lettenmaier L, Lutz L, Koidl L, Gentile S
J Clin Med. 2024; 13(1).
PMID: 38202282
PMC: 10779792.
DOI: 10.3390/jcm13010275.
Exploring the joint potential of inflammation, immunity, and receptor-based biomarkers for evaluating ME/CFS progression.
Berkis U, Svirskis S, Krumina A, Gravelsina S, Vilmane A, Araja D
Front Immunol. 2024; 14:1294758.
PMID: 38187396
PMC: 10771384.
DOI: 10.3389/fimmu.2023.1294758.
Integrated 'omics analysis for the gut microbiota response to moxibustion in a rat model of chronic fatigue syndrome.
Chaoran L, Yan Y, Chuwen F, Heng L, Yuanyuan Q, Yulin W
J Tradit Chin Med. 2023; 43(6):1176-1189.
PMID: 37946480
PMC: 10623263.
DOI: 10.19852/j.cnki.jtcm.20231018.004.
Investigating Antibody Reactivity to the Intestinal Microbiome in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Feasibility Study.
Seton K, Defernez M, Telatin A, Tiwari S, Savva G, Hayhoe A
Int J Mol Sci. 2023; 24(20).
PMID: 37895005
PMC: 10607161.
DOI: 10.3390/ijms242015316.
Chinese herbal medicine for the treatment of chronic fatigue syndrome: A systematic review and meta-analysis.
Zhang Y, Jin F, Wei X, Jin Q, Xie J, Pan Y
Front Pharmacol. 2022; 13:958005.
PMID: 36249791
PMC: 9557005.
DOI: 10.3389/fphar.2022.958005.
Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency.
Goschl L, Mrak D, Grabmeier-Pfistershammer K, Stiasny K, Haslacher H, Schneider L
Front Immunol. 2022; 13:974987.
PMID: 36189225
PMC: 9515892.
DOI: 10.3389/fimmu.2022.974987.
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Sukocheva O, Maksoud R, Beeraka N, Madhunapantula S, Sinelnikov M, Nikolenko V
J Adv Res. 2022; 40:179-196.
PMID: 36100326
PMC: 8619886.
DOI: 10.1016/j.jare.2021.11.013.
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch L, Zoller T
Nat Commun. 2022; 13(1):5104.
PMID: 36042189
PMC: 9426365.
DOI: 10.1038/s41467-022-32507-6.
[Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].
Renz-Polster H, Scheibenbogen C
Inn Med (Heidelb). 2022; 63(8):830-839.
PMID: 35925074
PMC: 9281337.
DOI: 10.1007/s00108-022-01369-x.
Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Lutz L, Rohrhofer J, Zehetmayer S, Stingl M, Untersmayr E
Biomolecules. 2021; 11(9).
PMID: 34572574
PMC: 8465819.
DOI: 10.3390/biom11091359.
Evaluating Routine Blood Tests According to Clinical Symptoms and Diagnostic Criteria in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Baklund I, Dammen T, Moum T, Kristiansen W, Duarte D, Castro-Marrero J
J Clin Med. 2021; 10(14).
PMID: 34300271
PMC: 8307418.
DOI: 10.3390/jcm10143105.
Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study.
Scheibenbogen C, Sotzny F, Hartwig J, Bauer S, Freitag H, Wittke K
J Clin Med. 2021; 10(11).
PMID: 34072494
PMC: 8198960.
DOI: 10.3390/jcm10112420.
European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe.
Nacul L, Authier F, Scheibenbogen C, Lorusso L, Helland I, Martin J
Medicina (Kaunas). 2021; 57(5).
PMID: 34069603
PMC: 8161074.
DOI: 10.3390/medicina57050510.
Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS.
Milivojevic M, Che X, Bateman L, Cheng A, Garcia B, Hornig M
PLoS One. 2020; 15(7):e0236148.
PMID: 32692761
PMC: 7373296.
DOI: 10.1371/journal.pone.0236148.
Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset.
Steiner S, Becker S, Hartwig J, Sotzny F, Lorenz S, Bauer S
Front Immunol. 2020; 11:578.
PMID: 32328064
PMC: 7161310.
DOI: 10.3389/fimmu.2020.00578.
Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology.
Germain A, Ruppert D, Levine S, Hanson M
Metabolites. 2018; 8(4).
PMID: 30563204
PMC: 6315598.
DOI: 10.3390/metabo8040090.